Your email has been successfully added to our mailing list.

×
0 0 0 0 0.0380622837370242 0.124567474048443 0.0813148788927335 0.0769896193771625
Stock impact report

Cancer Genetics down 28% on pricing equity offering [Seeking Alpha]

CANCER GENETICS (CGIX) 
Last cancer genetics earnings: 11/19 04:16 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.cancergenetics.com
Company Research Source: Seeking Alpha
Cancer Genetics down 28% on pricing equity offering Cancer Genetics (NASDAQ: CGIX priced Underwriter over-allotment is an additional 2M shares. The offering is expected to close on or about January 14. Net proceeds from the offering will be used to pay lender fees and other costs incurred in connection with the potential forbearance agreements it is negotiating with its banks, to pay certain costs previously incurred by it in connection with its terminated transaction with NovellusDx Ltd., and if any proceeds remain available, to fund working capital and other general corporate purposes. Show less Read more
Impact Snapshot
Event Time:
CGIX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for CGIX alerts
Opt-in for
CGIX alerts

from News Quantified
Opt-in for
CGIX alerts

from News Quantified